129Xe MRI Cardiopulmonary

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorBastiaan Driehuys

About this trial

The goal of this NIH-sponsored study is to characterize three biomarkers derived from 129Xe gas exchange MRI and to understand how they change in response to interventions.

Eligibility criteria

Qualifiers

Outpatients of either gender, age > 18

Willing and able to give informed consent and adhere to visit/protocol (Consent must be given before any study procedures are performed.)

Subject has no diagnosed pulmonary conditions

Subject has not smoked in the previous 5 years

Disqualifiers

MRI is contraindicated based on responses to MRI screening questionnaire

Subject is pregnant or lactating

Resting O2 saturation <90% with maximum supplemental O2 delivered by nasal canula

Respiratory illness of a bacterial or viral etiology within 30 days of MRI

Trial design

Treatments tested in this trial

  • Hyperpolarized Xe129
  • Oxygen Administration

Treatment groups

125 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Bastiaan Driehuys

Lead sponsor

Duke University

Sponsor institution

National Institutes of Health (NIH)

Collaborator